SARS-CoV-2 vaccines in China could reduce COVID-19-related respiratory syndromes and deaths: A retrospective cohort study

SARS-CoV-2 vaccines in China could reduce COVID-19-related respiratory syndromes and deaths: A retrospective cohort study

Background: Information is limited regarding the effectiveness of the inactivated vaccine for COVID-19 approved in China in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) when administered in real-world conditions. Methods: We retrospectively surveyed 1352 pat...

Full description

Bibliographic Details
Main Authors: Weiping Yao, Yunhui Chen, Qiyu Huang, Wanxia Luo, Yueming Chen, Chuanbo Xie
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Vaccine: X
Subjects:
COVID-19
Vaccines
Retrospective analysis
Mortality
Severe pneumonia
Online Access:http://www.sciencedirect.com/science/article/pii/S2590136224000214

Internet

http://www.sciencedirect.com/science/article/pii/S2590136224000214

Similar Items